BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Rakesh Dachineni, D. Ramesh Kumar, Eduardo Callegari, Siddharth S. Kesharwani, Ranjini Sankaranarayanan, Teresa Seefeldt, Hemachand Tummala, G. Jayarama Bhat. Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancerInternational Journal of Oncology 2017; 51(6): 1661 doi: 10.3892/ijo.2017.4167
2
Xiaohong Ruby Xu, George M. Yousef, Heyu Ni. Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agentsBlood 2018; 131(16): 1777 doi: 10.1182/blood-2017-05-743187
3
Xiao-Nv Xie, Jing Yu, Li-Hua Zhang, Zhi-Ying Luo, Dong-Sheng Ouyang, Ling-Jie Zheng, Chun-Yang Wang, Li Yang, Ling Chen, Zhi-Rong Tan. Relationship between polymorphisms of the lipid metabolism-related gene PLA2G16 and risk of colorectal cancer in the Chinese populationFunctional & Integrative Genomics 2019; 19(2): 227 doi: 10.1007/s10142-018-0642-8
4
James Ronald Lawrence, Gwendoline Joan Baxter, John Robert Paterson. Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications2020;  doi: 10.5772/intechopen.91706
5
Yue Guo, Yue Liu, Chengyue Zhang, Zheng-Yuan Su, Wenji Li, Mou-Tuan Huang, Ah-Ng Kong. The epigenetic effects of aspirin: the modification of histone H3 lysine 27 acetylation in the prevention of colon carcinogenesis in azoxymethane- and dextran sulfate sodium-treated CF-1 miceCarcinogenesis 2016; 37(6): 616 doi: 10.1093/carcin/bgw042
6
Octav Ginghina, Cornelia Nitipir. Colorectal Cancer - Diagnosis, Screening and Management2018;  doi: 10.5772/intechopen.72701
7
Nina J. Chu, Todd D. Armstrong, Elizabeth M. Jaffee. Nonviral Oncogenic Antigens and the Inflammatory Signals Driving Early Cancer Development as Targets for Cancer ImmunopreventionClinical Cancer Research 2015; 21(7): 1549 doi: 10.1158/1078-0432.CCR-14-1186
8
NaNa Keum, Edward L. Giovannucci. Pathology and Epidemiology of Cancer2017; : 391 doi: 10.1007/978-3-319-35153-7_21
9
Etheresia Pretorius, Albe C Swanepoel, Antoinette V Buys, Natasha Vermeulen, Wiebren Duim, Douglas B Kell. Eryptosis as a marker of Parkinson's diseaseAging 2014; 6(10): 788 doi: 10.18632/aging.100695
10
Suaka Kagbo-Kue, Taiwo Ajose, Nicolas Bakinde. Aspirin inhibited the metastasis of colon cancer cells by inhibiting the expression of toll-like receptor 4Cell & Bioscience 2018; 8(1) doi: 10.1186/s13578-018-0234-2
11
Sheng-Dean Luo, Wei-Chih Chen, Ching-Nung Wu, Yao-Hsu Yang, Shau-Hsuan Li, Fu-Min Fang, Tai-Lin Huang, Yu-Ming Wang, Tai-Jan Chiu, Shao-Chun Wu. Low-Dose Aspirin Use Significantly Improves the Survival of Late-Stage NPC: A Propensity Score-Matched Cohort Study in TaiwanCancers 2020; 12(6): 1551 doi: 10.3390/cancers12061551
12
Simone Mocellin, Annabel Goodwin, Sandro Pasquali. Risk-reducing medications for primary breast cancer: a network meta-analysisCochrane Database of Systematic Reviews 2019;  doi: 10.1002/14651858.CD012191.pub2
13
Olivier Fortin, Blanca Aguilar-Uscanga, Khanh Dang Vu, Stephane Salmieri, Monique Lacroix. Cancer Chemopreventive, Antiproliferative, and Superoxide Anion Scavenging Properties ofKluyveromyces marxianusandSaccharomyces cerevisiae var. boulardiiCell Wall ComponentsNutrition and Cancer 2018; 70(1): 83 doi: 10.1080/01635581.2018.1380204
14
Jun Li, Gary A. Cameron, Heather M. Wallace. Decreased sensitivity to aspirin is associated with altered polyamine metabolism in human prostate cancer cellsAmino Acids 2016; 48(4): 1003 doi: 10.1007/s00726-015-2143-6
15
Jolanta Hybiak, Izabela Broniarek, Gerard Kiryczyński, Laura.D. Los, Jakub Rosik, Filip Machaj, Hubert Sławiński, Kornelia Jankowska, Elżbieta Urasińska. Aspirin and its pleiotropic applicationEuropean Journal of Pharmacology 2020; 866: 172762 doi: 10.1016/j.ejphar.2019.172762
16
Qiuyuan Lin, Xin Ye, Zhipeng Huang, Bin Yang, Xueen Fang, Hui Chen, Jilie Kong. Graphene Oxide-Based Suppression of Nonspecificity in Loop-Mediated Isothermal Amplification Enabling the Sensitive Detection of Cyclooxygenase-2 mRNA in Colorectal CancerAnalytical Chemistry 2019; 91(24): 15694 doi: 10.1021/acs.analchem.9b03861
17
Xunlei Zhang, Xingsong Zhang, Lili Shen, Li Song, Jindong Wu, Guangxin Cao, Xin Chen, Bin Zhu. Comprehensive analysis of differentially expressed lncRNAs as diagnostic and prognostic markers for colorectal cancerExperimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.8067
18
Lenard M. Lichtenberger, K. Vinod Vijayan. Are Platelets the Primary Target of Aspirin's Remarkable Anticancer Activity?Cancer Research 2019; 79(15): 3820 doi: 10.1158/0008-5472.CAN-19-0762
19
Chen Sun, Fu-Jing Wang, Hao-Gang Zhang, Xun-Zheng Xu, Rui-Chun Jia, Lei Yao, Peng-Fei Qiao. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy <i>via</i> transforming growth factor-&beta;/Smad4 pathwayWorld Journal of Gastroenterology 2017; 23(10): 1816-1827 doi: 10.3748/wjg.v23.i10.1816
20
Etheresia Pretorius, Sthembile Mbotwe, Douglas B. Kell. Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbiditiesScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09860-4
21
Bei Li, Kaiming Su, Guang Yang, Yanmei Feng, Li Xia, Shankai Yin. Assessment of the Potential Ototoxicity of High-Dose Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, in RatsOtolaryngology–Head and Neck Surgery 2015; 152(6): 1108 doi: 10.1177/0194599815573702
22
Daniel Plano, Deepkamal N. Karelia, Manoj K. Pandey, Julian E. Spallholz, Shantu Amin, Arun K. Sharma. Design, Synthesis, and Biological Evaluation of Novel Selenium (Se-NSAID) Molecules as Anticancer AgentsJournal of Medicinal Chemistry 2016; 59(5): 1946 doi: 10.1021/acs.jmedchem.5b01503
23
Preeti Kanikarla-Marie, Michael Lam, David G. Menter, Scott Kopetz. Platelets, circulating tumor cells, and the circulomeCancer and Metastasis Reviews 2017; 36(2): 235 doi: 10.1007/s10555-017-9681-1
24
Simone Mocellin, Annabel Goodwin, Sandro Pasquali. Risk-reducing medication for primary breast cancer: a network meta-analysisCochrane Database of Systematic Reviews 2016;  doi: 10.1002/14651858.CD012191
25
Xiaoya Ma, Huabing Zhang, Xiang Xue, Yatrik M. Shah. Hypoxia-inducible factor 2α (HIF-2α) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activityJournal of Biological Chemistry 2017; 292(41): 17046 doi: 10.1074/jbc.M117.805655
26
Yan Tian, Yu Xu, Huawei Wang, Ruo Shu, Liang Sun, Yujian Zeng, Fangyou Gong, Yi Lei, Kunhua Wang, Huayou Luo. Comprehensive analysis of microarray expression profiles of circRNAs and lncRNAs with associated co-expression networks in human colorectal cancerFunctional & Integrative Genomics 2019; 19(2): 311 doi: 10.1007/s10142-018-0641-9
27
Isidro Cortes-Ciriano, Daniel S Murrell, Gerard JP van Westen, Andreas Bender, Thérèse E Malliavin. Prediction of the potency of mammalian cyclooxygenase inhibitors with ensemble proteochemometric modelingJournal of Cheminformatics 2015; 7(1) doi: 10.1186/s13321-014-0049-z
28
James R. Lawrence, Gwendoline J. Baxter, John R. Paterson. Aspirin for cancer is no mere antiplatelet prototype. There is potential in its ancient rootsMedical Hypotheses 2016; 94: 74 doi: 10.1016/j.mehy.2016.07.001
29
Shan Lu, Obinna N. Obianom, Yong Ai. Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancerBioorganic & Medicinal Chemistry Letters 2018; 28(17): 2869 doi: 10.1016/j.bmcl.2018.07.032
30
B. Ahmetaj-Shala, A. Tesfai, C. Constantinou, R. Leszczynski, M.V. Chan, H. Gashaw, G. Galaris, S. Mazi, T.D. Warner, N.S. Kirkby, J.A. Mitchell. Pharmacological assessment of ibuprofen arginate on platelet aggregation and colon cancer cell killingBiochemical and Biophysical Research Communications 2017; 484(4): 762 doi: 10.1016/j.bbrc.2017.01.161
31
Etheresia Pretorius, Janette Bester, Natasha Vermeulen, Sajee Alummoottil, Prashilla Soma, Antoinette V Buys, Douglas B Kell. Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnosticsCardiovascular Diabetology 2015; 14(1): 30 doi: 10.1186/s12933-015-0192-5
32
Yongguo Shi, Yangchen Liu, Jirong Wang, Ding Jie, Tian Yun, Wang Li, Lin Yan, Keming Wang, Jifeng Feng, Vinod Scaria. Downregulated Long Noncoding RNA BANCR Promotes the Proliferation of Colorectal Cancer Cells via Downregualtion of p21 ExpressionPLOS ONE 2015; 10(4): e0122679 doi: 10.1371/journal.pone.0122679
33
Mark A. Moyad. Prostate Cancer2016; : 169 doi: 10.1016/B978-0-12-800077-9.00020-7
34
George J. Tsioulias, Mae F. Go, Basil Rigas. NSAIDs and Colorectal Cancer Control: Promise and ChallengesCurrent Pharmacology Reports 2015; 1(5): 295 doi: 10.1007/s40495-015-0042-x
35
Yuxiang Sun, Hui Dai, Shaopeng Chen, Yajun Zhang, Tao Wu, Xianbin Cao, Guoping Zhao, An Xu, Jun Wang, Lijun Wu. Disruption of Chromosomal Architecture of cox2 Locus Sensitizes Lung Cancer Cells to RadiotherapyMolecular Therapy 2018; 26(10): 2456 doi: 10.1016/j.ymthe.2018.08.002
36
Hermann Brenner, Chen Chen. The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary preventionBritish Journal of Cancer 2018; 119(7): 785 doi: 10.1038/s41416-018-0264-x
37
Agnieszka Blazejczyk, Diana Papiernik, Kseniia Porshneva, Joanna Sadowska, Joanna Wietrzyk. Endothelium and cancer metastasis: Perspectives for antimetastatic therapyPharmacological Reports 2015; 67(4): 711 doi: 10.1016/j.pharep.2015.05.014
38
Xiu-Fen Liu, Ji-Long Hao, Tian Xie, Om Prakash Pant, Cheng-Bo Lu, Cheng-Wei Lu, Dan-Dan Zhou. The BRAF activated non-coding RNA: A pivotal long non-coding RNA in human malignanciesCell Proliferation 2018; 51(4): e12449 doi: 10.1111/cpr.12449
39
Nipun Choudhry, Ankita Kaushal. An overview of colorectral cancerApollo Medicine 2015; 12(3): 194 doi: 10.1016/j.apme.2015.07.015
40
Preeti Kanikarla-Marie, Michael Lam, Alexey V. Sorokin, Michael J. Overman, Scott Kopetz, David G. Menter. Platelet Metabolism and Other Targeted Drugs; Potential Impact on ImmunotherapyFrontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00107